The monoclonal antibody MEL‐14 can block lymphocyte migration into a site ofchronic inflammation
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effect of MEL‐14, a monoclonal antibody which binds to the lymphocyte homing receptor (MEL‐14 Ag) on lymphocytes for peripheral lymph node (PLN) high endothelial venules (HEV), was investigated on lymphocyte migration into a delayed‐type hypersensitivity (DTH)‐like lesion produced by sensitization and challenge to Bordetella pertussis vaccine (BPV). Pretreatment of lymphocytes with saturating concentrations of MEL‐14 caused a highly significant inhibition of lymphocyte migration into the chronically inflamed site and PLN. This finding suggests that lymphocyte migration into the BPV‐induced site of chronic inflammation may be regulated by the same mechanism as lymphocyte migration into the PLN. It further indicates that the ligand for the MEL‐14 Ag adhesion molecule, recognized by lymphocyte which home to the PLN, may also be expressed on HEV‐like vessels at sites of BPV‐induced chronic inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spertini, O., Luscinskas, F. W., Kansas, G. S., Munro, J. M., Griffin, J. D., Gimbrone, M. A., & Tedder, T. F. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2565 · Cited by 394
Cited by
Dutton, R. W., Bradley, L. M., & Swain, S. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.201 · Cited by 832
L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites.
Tedder, T. F., Steeber, D. A., & Pizcueta, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2259 · Cited by 432
Bowen, D. G., Zen, M., Holz, L., Davis, T., McCaughan, G. W., & Bertolino, P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21593 · Cited by 316
Calcium-Dependent Heparin-Like Ligands For L-Selectin in Nonlymphoid Endothelial Cells
Norgard-Sumnicht, K. E., Varki, N. M., & Varki, A. (1993) · Science · doi:10.1126/science.7687382 · Cited by 197
Metadata
- Authors
- Dawson, J., Sedgwick, A. D., Edwards, J. C. W., & Lees, P.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1992-06
- Volume
- 22
- Issue
- 6
- Pages
- 1647-1650
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2132134585
- Cited by
- 37
- References
- 1
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The monoclonal antibody MEL‐14 can block lymphocyte migration into a site ofchronic inflammation. https://app.cochat.ai/papers/10.1002/eji.1830220646
- The paper
- Dawson, J., Sedgwick, A. D., Edwards, J. C. W., & Lees, P. (1992). The monoclonal antibody MEL‐14 can block lymphocyte migration into a site ofchronic inflammation. European Journal of Immunology. https://doi.org/10.1002/eji.1830220646
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.